Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. has demonstrated significant growth potential, particularly within its Integrated Senior Health Campuses and Senior Housing Operating Property segments, which experienced year-over-year increases of 28% and 66.6%, respectively. The company is projecting robust earnings growth, with expected normalized FFO per share growth of 2.1% in 2024, 18.3% in 2025, and an average of 9.0% per year from 2024 to 2029, positioning it as a leader in its healthcare REIT coverage universe. Additionally, the company has successfully reduced its leverage, facilitating a more favorable cost of capital for pursuing further investment opportunities, thus strengthening its overall financial stability.

Bears say

American Healthcare REIT Inc. faces several risks that contribute to a negative outlook on its stock, including tenant risk, acquisition risk, and ongoing challenges related to development and redevelopment. The company's financial guidance indicates a slight reduction in its 2025 Core FFO to $1.58 per share, suggesting potential difficulties in achieving organic NOI growth expectations that could adversely affect its performance. Additionally, ongoing labor deficiencies and economic headwinds may further strain tenant operations, thereby impacting the REIT's earnings power and overall financial stability.

AHR has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 2 analysts, AHR has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $39, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $39, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.